Banks - Regional
Compare Stocks
4 / 10Stock Comparison
BLFY vs CHMG vs NBTB vs NFBK
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
BLFY vs CHMG vs NBTB vs NFBK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional |
| Market Cap | $275M | $331M | $2.35B | $588M |
| Revenue (TTM) | $97M | $140M | $867M | $251M |
| Net Income (TTM) | $-10M | $15M | $169M | $39M |
| Gross Margin | 48.4% | 64.2% | 72.1% | 49.1% |
| Operating Margin | -10.3% | 14.2% | 25.3% | 16.1% |
| Forward P/E | — | 9.6x | 10.8x | 10.4x |
| Total Debt | $324M | $5M | $327M | $760M |
| Cash & Equiv. | $53M | $23M | $185M | $168M |
BLFY vs CHMG vs NBTB vs NFBK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 21 | Apr 26 | Return |
|---|---|---|---|
| Blue Foundry Bancorp (BLFY) | 100 | 106.9 | +6.9% |
| Chemung Financial C… (CHMG) | 100 | 118.3 | +18.3% |
| NBT Bancorp Inc. (NBTB) | 100 | 122.2 | +22.2% |
| Northfield Bancorp,… (NFBK) | 100 | 82.3 | -17.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BLFY vs CHMG vs NBTB vs NFBK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BLFY lags the leaders in this set but could rank higher in a more targeted comparison.
CHMG carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.
- 198.0% 10Y total return vs NBTB's 102.2%
- Lower volatility, beta 0.73, Low D/E 1.9%, current ratio 0.13x
- NIM 3.2% vs NFBK's 2.0%
- Better valuation composite
NBTB is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 12 yrs, beta 0.89, yield 3.2%
- Beta 0.89, yield 3.2%, current ratio 1.60x
- 3.2% yield, 12-year raise streak, vs NFBK's 3.7%, (1 stock pays no dividend)
NFBK is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 13.9%, EPS growth -16.3%
- 13.9% NII/revenue growth vs CHMG's -6.5%
- Efficiency ratio 0.3% vs BLFY's 0.6% (lower = leaner)
- Efficiency ratio 0.3% vs BLFY's 0.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 13.9% NII/revenue growth vs CHMG's -6.5% | |
| Value | Better valuation composite | |
| Quality / Margins | Efficiency ratio 0.3% vs BLFY's 0.6% (lower = leaner) | |
| Stability / Safety | Beta 0.73 vs BLFY's 1.34, lower leverage | |
| Dividends | 3.2% yield, 12-year raise streak, vs NFBK's 3.7%, (1 stock pays no dividend) | |
| Momentum (1Y) | +54.5% vs NBTB's +9.0% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs BLFY's 0.6% |
BLFY vs CHMG vs NBTB vs NFBK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
BLFY vs CHMG vs NBTB vs NFBK — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NBTB leads in 2 of 6 categories
CHMG leads 1 • BLFY leads 0 • NFBK leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NBTB leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
NBTB is the larger business by revenue, generating $867M annually — 8.9x BLFY's $97M. NBTB is the more profitable business, keeping 19.5% of every revenue dollar as net income compared to BLFY's -10.3%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $97M | $140M | $867M | $251M |
| EBITDAEarnings before interest/tax | -$7M | $22M | $241M | $61M |
| Net IncomeAfter-tax profit | -$10M | $15M | $169M | $39M |
| Free Cash FlowCash after capex | -$8M | $47M | $225M | $42M |
| Gross MarginGross profit ÷ Revenue | +48.4% | +64.2% | +72.1% | +49.1% |
| Operating MarginEBIT ÷ Revenue | -10.3% | +14.2% | +25.3% | +16.1% |
| Net MarginNet income ÷ Revenue | -10.3% | +10.8% | +19.5% | +11.9% |
| FCF MarginFCF ÷ Revenue | -8.6% | +1.4% | +25.2% | +11.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -46.2% | +29.8% | +39.5% | +68.8% |
Valuation Metrics
Evenly matched — NBTB and NFBK each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 13.5x trailing earnings, NBTB trades at a 39% valuation discount to CHMG's 22.0x P/E. On an enterprise value basis, NBTB's 10.4x EV/EBITDA is more attractive than NFBK's 24.2x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $275M | $331M | $2.4B | $588M |
| Enterprise ValueMkt cap + debt − cash | $597M | $314M | $2.5B | $1.2B |
| Trailing P/EPrice ÷ TTM EPS | -24.07x | 22.01x | 13.53x | 19.54x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 9.64x | 10.80x | 10.42x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.92x | — |
| EV / EBITDAEnterprise value multiple | — | 15.73x | 10.35x | 24.19x |
| Price / SalesMarket cap ÷ Revenue | 3.15x | 2.37x | 2.71x | 2.34x |
| Price / BookPrice ÷ Book value/share | 0.86x | 1.30x | 1.21x | 0.83x |
| Price / FCFMarket cap ÷ FCF | 55.84x | 163.62x | 10.75x | 19.64x |
Profitability & Efficiency
NBTB leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
NBTB delivers a 9.5% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-3 for BLFY. CHMG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to NFBK's 1.08x. On the Piotroski fundamental quality scale (0–9), NBTB scores 7/9 vs CHMG's 3/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -3.1% | +6.3% | +9.5% | +5.5% |
| ROA (TTM)Return on assets | -0.5% | +0.5% | +1.1% | +0.7% |
| ROICReturn on invested capital | -1.1% | +5.0% | +7.9% | +2.0% |
| ROCEReturn on capital employed | -1.5% | +5.6% | +2.4% | +2.5% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 3 | 7 | 7 |
| Debt / EquityFinancial leverage | 1.04x | 0.02x | 0.17x | 1.08x |
| Net DebtTotal debt minus cash | $271M | -$18M | $142M | $592M |
| Cash & Equiv.Liquid assets | $53M | $23M | $185M | $168M |
| Total DebtShort + long-term debt | $324M | $5M | $327M | $760M |
| Interest CoverageEBIT ÷ Interest expense | -0.21x | 0.44x | 1.05x | 0.46x |
Total Returns (Dividends Reinvested)
CHMG leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CHMG five years ago would be worth $17,043 today (with dividends reinvested), compared to $10,018 for NFBK. Over the past 12 months, CHMG leads with a +54.5% total return vs NBTB's +9.0%. The 3-year compound annual growth rate (CAGR) favors CHMG at 27.7% vs BLFY's 14.3% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +5.8% | +27.0% | +9.3% | +26.5% |
| 1-Year ReturnPast 12 months | +33.7% | +54.5% | +9.0% | +31.5% |
| 3-Year ReturnCumulative with dividends | +49.2% | +108.2% | +54.1% | +65.7% |
| 5-Year ReturnCumulative with dividends | +2.6% | +70.4% | +29.9% | +0.2% |
| 10-Year ReturnCumulative with dividends | +2.6% | +198.0% | +102.2% | +20.6% |
| CAGR (3Y)Annualised 3-year return | +14.3% | +27.7% | +15.5% | +18.3% |
Risk & Volatility
Evenly matched — CHMG and NFBK each lead in 1 of 2 comparable metrics.
Risk & Volatility
CHMG is the less volatile stock with a 0.73 beta — it tends to amplify market swings less than BLFY's 1.34 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NFBK currently trades 99.0% from its 52-week high vs BLFY's 89.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.34x | 0.73x | 0.89x | 1.00x |
| 52-Week HighHighest price in past year | $14.74 | $70.83 | $46.92 | $14.21 |
| 52-Week LowLowest price in past year | $7.61 | $43.20 | $39.20 | $9.90 |
| % of 52W HighCurrent price vs 52-week peak | +89.8% | +97.3% | +96.1% | +99.0% |
| RSI (14)Momentum oscillator 0–100 | 54.3 | 67.4 | 57.3 | 57.0 |
| Avg Volume (50D)Average daily shares traded | 271K | 10K | 236K | 258K |
Analyst Outlook
Evenly matched — NBTB and NFBK each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BLFY as "Hold", CHMG as "Hold", NBTB as "Hold", NFBK as "Hold". Consensus price targets imply 3.1% upside for NFBK (target: $15) vs -27.4% for CHMG (target: $50). For income investors, NFBK offers the higher dividend yield at 3.73% vs CHMG's 1.91%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | $12.00 | $50.00 | $46.00 | $14.50 |
| # AnalystsCovering analysts | 3 | 7 | 10 | 9 |
| Dividend YieldAnnual dividend ÷ price | — | +1.9% | +3.2% | +3.7% |
| Dividend StreakConsecutive years of raises | — | 0 | 12 | 10 |
| Dividend / ShareAnnual DPS | — | $1.31 | $1.43 | $0.52 |
| Buyback YieldShare repurchases ÷ mkt cap | +7.1% | 0.0% | +0.4% | +3.2% |
NBTB leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CHMG leads in 1 (Total Returns). 3 tied.
BLFY vs CHMG vs NBTB vs NFBK: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BLFY or CHMG or NBTB or NFBK a better buy right now?
For growth investors, Northfield Bancorp, Inc.
(NFBK) is the stronger pick with 13. 9% revenue growth year-over-year, versus -6. 5% for Chemung Financial Corporation (CHMG). NBT Bancorp Inc. (NBTB) offers the better valuation at 13. 5x trailing P/E (10. 8x forward), making it the more compelling value choice. Analysts rate Blue Foundry Bancorp (BLFY) a "Hold" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BLFY or CHMG or NBTB or NFBK?
On trailing P/E, NBT Bancorp Inc.
(NBTB) is the cheapest at 13. 5x versus Chemung Financial Corporation at 22. 0x. On forward P/E, Chemung Financial Corporation is actually cheaper at 9. 6x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — BLFY or CHMG or NBTB or NFBK?
Over the past 5 years, Chemung Financial Corporation (CHMG) delivered a total return of +70.
4%, compared to +0. 2% for Northfield Bancorp, Inc. (NFBK). Over 10 years, the gap is even starker: CHMG returned +198. 0% versus BLFY's +2. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BLFY or CHMG or NBTB or NFBK?
By beta (market sensitivity over 5 years), Chemung Financial Corporation (CHMG) is the lower-risk stock at 0.
73β versus Blue Foundry Bancorp's 1. 34β — meaning BLFY is approximately 83% more volatile than CHMG relative to the S&P 500. On balance sheet safety, Chemung Financial Corporation (CHMG) carries a lower debt/equity ratio of 2% versus 108% for Northfield Bancorp, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — BLFY or CHMG or NBTB or NFBK?
By revenue growth (latest reported year), Northfield Bancorp, Inc.
(NFBK) is pulling ahead at 13. 9% versus -6. 5% for Chemung Financial Corporation (CHMG). On earnings-per-share growth, the picture is similar: NBT Bancorp Inc. grew EPS 12. 5% year-over-year, compared to -36. 9% for Chemung Financial Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BLFY or CHMG or NBTB or NFBK?
NBT Bancorp Inc.
(NBTB) is the more profitable company, earning 19. 5% net margin versus -10. 3% for Blue Foundry Bancorp — meaning it keeps 19. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NBTB leads at 25. 3% versus -10. 3% for BLFY. At the gross margin level — before operating expenses — NBTB leads at 72. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BLFY or CHMG or NBTB or NFBK more undervalued right now?
On forward earnings alone, Chemung Financial Corporation (CHMG) trades at 9.
6x forward P/E versus 10. 8x for NBT Bancorp Inc. — 1. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NFBK: 3. 1% to $14. 50.
08Which pays a better dividend — BLFY or CHMG or NBTB or NFBK?
In this comparison, NFBK (3.
7% yield), NBTB (3. 2% yield), CHMG (1. 9% yield) pay a dividend. BLFY does not pay a meaningful dividend and should not be held primarily for income.
09Is BLFY or CHMG or NBTB or NFBK better for a retirement portfolio?
For long-horizon retirement investors, Chemung Financial Corporation (CHMG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
73), 1. 9% yield, +198. 0% 10Y return). Both have compounded well over 10 years (CHMG: +198. 0%, BLFY: +2. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BLFY and CHMG and NBTB and NFBK?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: BLFY is a small-cap quality compounder stock; CHMG is a small-cap quality compounder stock; NBTB is a small-cap deep-value stock; NFBK is a small-cap income-oriented stock. CHMG, NBTB, NFBK pay a dividend while BLFY does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.